← Back to dashboard
ISRG Robotics & Physical AI Surgical robotics leader Open in compare 3D performance Excel model

Intuitive Surgical

Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.

Live metrics are partially unavailable

1 of 21 live fields are unavailable right now. The chart, thesis sections, and source links still make the page usable.

20 live 1 unavailable
Price $378.81 Live
1D Change +1.36% 1 day
Market Cap $135.72B Live
Enterprise Value $128.74B Current
Trailing P/E 43.5 TTM
Forward P/E 31.4 Forward
PEG Ratio 1.83x Yahoo est.
Price / Sales 12.3 TTM
EV / Revenue 11.7 TTM
Revenue Growth 18.5% YoY latest qtr
Earnings Growth 26.5% YoY latest qtr
Gross Margin 66.7% TTM
Operating Margin 33.6% TTM
Net Margin 28.4% TTM
ROE 17.4% TTM
Free Cash Flow $2.62B TTM
FCF Margin 23.7% TTM
Debt / Equity Latest qtr
Current Ratio 4.96x Latest qtr
Dividend Yield 0.00% Annualized
Next Earnings Oct 20, 2026 Calendar

Metric timing

This page mixes live market data, trailing fundamentals, and latest reported statement data.

Live / market snapshot

Price, 1D change, market cap, and enterprise value are current market-based figures.

TTM / forward

Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.

Latest quarter / dividend cadence

Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.

Revenue $10.06B Dec 31, 2025

latest annual revenue

Revenue $2.89B Jun 30, 2026

latest quarterly revenue

Net Income $2.86B Dec 31, 2025

latest annual profit

Net Income $818.1M Jun 30, 2026

latest quarterly profit

Dividend / Share $0.00 No regular dividend

annualized per share

Last Dividend No dividend history

latest ex-dividend cash amount

Price chart

Data loads live when the page opens.

Latest headlines

Recent company headlines. Each link opens the original article in a new tab.

Motley Fool Aug 08, 2026
Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

They are going through a rough patch, but it's too early to give up on them.

Motley Fool Aug 08, 2026
Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech

Intuitive Surgical is a leader in the surgical robotics space, with a large installed base and strong recurring revenues.

24/7 Wall St. Aug 08, 2026
The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%

Intuitive Surgical has shed a third of its value while its robotic surgery peers barely flinched, and Wall Street's most bullish analyst sees an outcome that would leave anyone who sold near the bottom regretting it.

Zacks Aug 06, 2026
Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?

Intuitive Surgical's da Vinci 5 is gaining rapid adoption, fueling hospital upgrades as software enhancements build a potential multi-year capital cycle.

Motley Fool Aug 05, 2026
3 Beaten-Down Stocks to Hold for the Next 10 Years

Don't let their recent poor performances chase you away.

Insider Monkey Aug 04, 2026
Baron Capital Sees Years of Mid-Teens Growth for Intuitive Surgical (ISRG)

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]

Why it could benefit going forward

  • Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
  • Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
  • This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.

Moat / edge

  • Large installed base and deep surgeon training ecosystem.
  • Recurring revenue from instruments, accessories, and service.
  • Years of lead time and brand strength in robotic-assisted surgery.

What to watch

  • Procedure growth and system placements.
  • Adoption of newer da Vinci platforms and adjacent products.
  • Gross-margin resilience as the business scales.

Key risks

  • Premium valuation can leave less room for execution misses.
  • Hospital capital-spending cycles still matter.

Business snapshot

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.